LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 45 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $2,802,000 | -65.4% | 2,835,000 | -63.8% | 0.00% | -66.7% |
Q1 2021 | $8,098,000 | -14.5% | 7,824,000 | -22.3% | 0.01% | -18.2% |
Q4 2020 | $9,475,000 | +4.3% | 10,069,000 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $9,081,000 | +123.9% | 10,069,000 | +117.7% | 0.01% | +120.0% |
Q2 2020 | $4,056,000 | -38.3% | 4,625,000 | -39.3% | 0.01% | -37.5% |
Q4 2019 | $6,576,000 | +3.5% | 7,620,000 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $6,351,000 | +1.2% | 7,620,000 | +4.8% | 0.01% | 0.0% |
Q2 2019 | $6,276,000 | – | 7,269,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CANYON CAPITAL ADVISORS LLC | 40,000,000 | $39,863,000 | 1.36% |
TFG Asset Management GP Ltd | 21,600,000 | $21,837,000 | 1.32% |
Penn Mutual Asset Management | 810 | $806,000 | 0.86% |
WOLVERINE ASSET MANAGEMENT LLC | 47,643,000 | $47,931,000 | 0.45% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,750,000 | 0.25% |
OAKTREE CAPITAL MANAGEMENT LP | 18,672,000 | $18,683,000 | 0.20% |
PALISADE CAPITAL MANAGEMENT, LP | 9,833,000 | $9,883,000 | 0.20% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 10,000,000 | $9,956,000 | 0.15% |
SSI INVESTMENT MANAGEMENT LLC | 2,500,000 | $2,490,000 | 0.15% |
AVIVA PLC | 31,500,000 | $31,724,000 | 0.13% |